4//SEC Filing
Schuetz Thomas J. 4
Accession 0001171843-23-000557
CIK 0001738021other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 10:14 AM ET
Size
5.5 KB
Accession
0001171843-23-000557
Insider Transaction Report
Form 4
Schuetz Thomas J.
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Purchase
Common Stock
2023-01-31$4.05/sh+20,000$81,000→ 5,471,873 total
Footnotes (1)
- [F1]112,449 of these shares of common stock underlie unvested restricted stock awards that are subject to a right of repurchase in favor of the issuer, which vest as follows: restricted stock award granted on July 3, 2019, with the remaining 39,112 shares vesting approximately equally per month with shares fully vested on July 31, 2023 and restricted stock award granted on December 20, 2019, with the remaining 73,337 shares vesting approximately equally per month with shares fully vested on December 31, 2023. 450,000 of the shares represents unvested restricted stock units ("RSU") granted to the reporting person on November 16, 2021. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vested on November 15, 2022.
Documents
Issuer
Compass Therapeutics, Inc.
CIK 0001738021
Entity typeother
Related Parties
1- filerCIK 0001591464
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 10:14 AM ET
- Size
- 5.5 KB